OrthoPediatrics sees FY25 revenue of $236.1M
2026-01-12 07:50:31 ET
More on OrthoPediatrics
- OrthoPediatrics Corp. (KIDS) Q3 2025 Earnings Call Transcript
- OrthoPediatrics outlines path to 12% baseline growth and free cash flow breakeven by 2026 amid clinic expansion and strong T&D momentum
- Seeking Alpha’s Quant Rating on OrthoPediatrics
- Historical earnings data for OrthoPediatrics
- Financial information for OrthoPediatrics
Read the full article on Seeking Alpha
For further details see:
OrthoPediatrics sees FY25 revenue of $236.1MNASDAQ: KIDS
KIDS Trading
1.31% G/L:
$17.84 Last:
69,804 Volume:
$17.55 Open:



